Stock 300725 PHARMABLOCK SCIENCES (NANJING), INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News PharmaBlock Sciences (Nanjing), Inc.

Equities

300725

CNE1000035K5

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-02 EDT 		5-day change 1st Jan Change
30.59 CNY -2.36% Intraday chart for PharmaBlock Sciences (Nanjing), Inc. -2.30% -22.10%
04-23 PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-01 Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
PharmaBlock Sciences, Inc. Approves Cash Dividend for the Year 2023
CI
PharmaBlock Proposes Final Dividend for 2023
CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.
CI
Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.
CI
Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.
CI
PharmaBlock Sciences, Inc Opens HPAPI GMP Facility at Zhejiang Manufacturing Site
CI
PharmaBlock Sciences, Inc.(SZSE:300725) dropped from Shenzhen Stock Exchange Component A Share Index
CI
PharmaBlock Sciences, Inc.(SZSE:300725) dropped from Shenzhen Stock Exchange Component Index
CI
PharmaBlock Sciences, Inc. announces an Equity Buyback for CNY 40 million worth of its shares.
CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
PharmaBlock Sciences, Inc. authorizes a Buyback Plan.
CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Pharmablock Sciences, Inc. Announces Final Dividend on Share A for 2022, Payable in June 13, 2023
CI
Pharmablock Sciences, Inc. Approves Election of Jie Yuanping and Wu Juanjuan as Non-Independent Directors
CI
Pharmablock Sciences, Inc. Approves Final Cash Dividend for the Year 2022
CI
PharmaBlock Sciences, Inc. Proposes Final Cash Dividend for the Year 2022
CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
PharmaBlock Opens New R&D Facility in Pennsylvania
CI
PharmaBlock Sciences, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300725 Stock
  4. News PharmaBlock Sciences (Nanjing), Inc.